|
| L-Phenylalaninamide, N-[2-[4-(sulfooxy)phenyl]acetyl]-L-norleucylglycyl-L-tryptophyl-L-norleucyl-N-methyl-L-α-aspartyl- Basic information |
| L-Phenylalaninamide, N-[2-[4-(sulfooxy)phenyl]acetyl]-L-norleucylglycyl-L-tryptophyl-L-norleucyl-N-methyl-L-α-aspartyl- Chemical Properties |
density | 1.345±0.06 g/cm3(Predicted) | pka | -4.26±0.18(Predicted) |
| L-Phenylalaninamide, N-[2-[4-(sulfooxy)phenyl]acetyl]-L-norleucylglycyl-L-tryptophyl-L-norleucyl-N-methyl-L-α-aspartyl- Usage And Synthesis |
Description | ARL 15849XX is a CCK-8 analog and a novel anti-obesity agent. |
| L-Phenylalaninamide, N-[2-[4-(sulfooxy)phenyl]acetyl]-L-norleucylglycyl-L-tryptophyl-L-norleucyl-N-methyl-L-α-aspartyl- Preparation Products And Raw materials |
|